Introduction
============

The International Agency for Research on Cancer (IARC) and the World Health Organization (WHO) published in the World Health Report 2014 with the prediction of 27 million new cancer cases by the year 2030 resulting in 17 million deaths and 75 million people living with cancer annually. Cancer is one of the major public health problems worldwide ([@B74]; [@B16]), occupying the second position of global incidence ([@B16]). In Brazil, approximately 600,000 new cancer cases every year are estimated ([@B38]).

Breast cancer is a multifactorial disease with more incidences in elderly patients ([@B6]). According to literature, more than 1.7 million cases are diagnosed worldwide ([@B1]), where one in eight women will probably develop breast cancer ([@B61]). Recent data has pointed out the association between genetic instability and cancer on the prognosis and disease progression ([@B23]). The mechanisms associated are telomere damage, centrosomal amplification, epigenetic modifications, and genotoxic DNA damage. These genomic alterations may lead to aneuploidy, induction of mutations, apoptosis, and necrosis ([@B12]; [@B15]; [@B30]). Several factors increased the risk of genetic instability in cancer development such as age, endocrine/reproductive history, behavioral/environmental factors, smoking, alcoholism, exposure to ionizing radiation, and hereditary factors ([@B3]; [@B47]; [@B16]).

Many cancer cells exhibited aneuploidies and chromosomal alterations leading to genetic instability which is a hallmark of cancer. Genetic heterogeneity is a problem for cancer therapies especially therapies targeting specific molecules. Thus, understanding the pathophysiology of genetic makeup is required to advance the prevention and cure of cancer ([@B68]). Biomonitoring of molecular alterations can be an important tool for better understanding of cancer biology which not only secure more accurate diagnoses but also ensure treatment success of cancer ([@B2]). For this, the comet assay is increasingly being used for the detection of genotoxicity ([@B26]) as well as the micronucleus test to evaluate chromosomal mutagenesis in eukaryotes such as clastogenesis (loss of chromosome fragments) and aneugenesis (loss or gain of whole chromosomes) and cell death ([@B29]).

Clinical and epidemiological studies are current priorities for understanding breast cancer heterogeneity especially aspects related to tumor etiology, chemoprophylaxis, and therapies, which are important strategies to improve prevention, diagnosis, prognosis and therapy efficacy ([@B8]; [@B1]). Thus, because of the influence of several risk factors for the etiology of breast cancer as a confounding element in genetic instability analysis induced during cancer therapies. The present study aimed to evaluate the correlations between sociocultural, occupational and life style risk factors with the levels of genetic instabilities during the first diagnosis and during chemotherapy (QT) and radiotherapy (RT). This study used toxicological biomarkers as indicative of nuclear abnormalities and genotoxicity in non-neoplastic cellular samples of the buccal epithelium and peripheral blood of breast cancer patients.

Materials and Methods {#s1}
=====================

Individuals
-----------

All patients were informed of the procedures and provided a written informed consent prior to sample collection. This study was performed in compliance with the Helsinki Declaration and was approved by the ethics committee of the Centro Universitário UNINOVAFAPI, Brazil (approval number: 0406.0.043.000-11). Between 2012 and 2015, 150 individuals were attended at the São Marcos Hospital where 100 patients were diagnosed with breast cancer including 83 with invasive ductal carcinoma (83%), three with invasive lobular carcinoma (3%), three with ductal carcinoma *in situ* (3%), three with medullary carcinoma (3%), and three with phyllodes tumor (3%). A total of 50 healthy women were enrolled as controls. All breast cancer patients were in between stage I and III based on TNM staging system (TNM classification of malignant tumors). The QT group of patients received two different QT protocols: standard FAC QT (fluorouracil 500 mg/m^2^, doxorubicin 50 mg/m^2^, cyclophosphamide 500 mg/m^2^---all i.v.) or AC-T QT (doxorubicin 50 mg/m^2^ and cyclophosphamide 500 mg/m^2^ i.v.) for 21 days including 80 mg/m^2^ of docetaxel (Taxotere) weekly for 12 weeks. Patients of RT group received 25 sessions of RT isolated or after QT with a total dose of 4500--5000 cGy (180--200 cGy/fraction). Breast cancer patients who presented renal and liver dysfunctions were excluded from this study.

Sample Collection
-----------------

Peripheral blood and buccal mucosa cells were samples and processed on the same day. Four collections were performed in breast cancer patients: (1) at the time of breast cancer diagnosis, prior to treatment; (2) at the second cycle of QT; (3) at the third week of QT; (4) at the fourth week of QT. Additionally, four collections were performed during RT: (1) before the RT; (2) at the second cycle of RT; (3) at the third week of QT; (4) 21 days after the last RT session. Blood collection was performed on the non-mastectomized side arm vein. For the Micronucleus Test, samples of oral mucosa were obtained by means of cytobrush brushes and stored in microtubes with 0.9% saline, duly identified. The samples were kept under refrigeration (4°C) until processing of the Micronucleus Test and Comet Assay at the Laboratory of Toxicological Genetics of the Federal University of Piauí---UFPI which served as support for the experiments.

Survey
------

The questionnaire for the *International Commission for Protection against Environmental Mutagens and Carcinogens* (ICPEMC) proposed by [@B17] was applied during the monitoring of cancer patients during diagnosis and cancer therapies (QT and RT). The questionnaire was related to various risk factors such as age, lifestyle, environmental, and occupational exposure aspects, family history, diseases, and nutritional factors. It was adapted to meet the needs of the study as well as to include information provided by patients during anamnesis including the use of alternative therapies as a therapeutic source during cancer treatment. The various risk factors were observed according to their frequencies and statistically correlated with genetic instability biomarkers such as DNA damage and apoptosis in non-neoplastic cells of patients before and during QT and RT.

Genomic Instability Analysis
----------------------------

### Comet Assay in Peripheral Blood Cells

After blood collection, samples were immediately processed according to [@B60] with modifications. The results were expressed as damage index (DI) and frequency of damage (DF). The DI was obtained by evaluating the tail type which was classified from 0 to 4 (50 cells per slide in duplicate, i.e., 100 per individual). Class 0 (C0, genetic material without damage or intact); class 1 (C1, mild damage); class 2 (C2, moderate damage); class 3 (C3, severe damage); and class 4 (C4, maximum damage). In order to determine DI, the total score for each individual was between 0 and 400 arbitrary units, and was defined as: DI: 0 × (C0) + 1 × (C1) + 2 × (C2) + 3 × (C3) + 4 × (C4). Each image was scored according to the extent of DNA migration based on a visual analysis in 100 cells of each slide. The DF analysis, varying from 0 to 100 (%), was define as: DF = 100 - C0, in which C0 represents the number of class 0 cells out of 100 cells evaluated.

### Micronucleus Test in Buccal Epithelial Cells

The micronucleus test in buccal epithelial cells was performed according to [@B70]. The incidence of micronuclei and nuclear abnormalities representing cell death (karyorrhexis and karyolysis) were observed in 2000 cells per patient using an optical microscope (Olympus, CX, United States) at 1000× magnification.

Statistical Analysis
--------------------

Statistical analysis was performed using SPSS version 13.0 (IBM Corp., Armonk, United States) for the analysis of variance with the non-parametric one-way ANOVA test and Spearman correlations. Kruskal--Wallis test was used to compare the hematological and biochemical parameters and the Student's *t*-test for comparisons between the exposed and non-exposed individuals in the genotoxic evaluation. Significance levels of up to *p* \< 0.05 were adopted.

Results and Discussion
======================

Patients Characteristics
------------------------

Socioeconomic factors, environmental and behavioral risks, psychosocial, educational and occupational aspects, lifestyle and stress levels have influenced the risk of breast cancer ([@B47]; [@B53]). Ethnicity is an important factors for the etiology of breast cancer ([@B21]). As observed in the study, the vast majority (70--80%) of cancer patients reported were of Caucasian ethnicity (**Table [1](#T1){ref-type="table"}**). Studies indicate that the incidence of breast cancer is 124 cases per 100,000 white women and 113 cases per 100,000 black women ([@B5]).

###### 

Sociocultural characterization of occupational risks, lifestyle for breast cancer in non-diagnosed patients.

  Features                    Control group (*n* = 50)   Chemotherapy (*n* = 50)   Radiotherapy (*n* = 50)
  --------------------------- -------------------------- ------------------------- -------------------------
  **Sociocultural**                                                                
  *Etnia*                                                                          
  Caucasian                   50%                        78%^∗^                    82%^∗^
  Black                       34%                        22%                       16%
  Other                       16%                        --                        2%
  *Age*^a^                    48.3 ± 13.4                49.8 ± 10.6               50.4 ± 11.9
  **Occupational risks**                                                           
  *Working time*                                                                   
  1--2 years                  8%                         6%                        6%
  2--4 years                  14%                        6%                        --
  4--8 years                  6%                         4%                        6%
  More than 8 years           72%                        84%                       88%
  **Working place**                                                                
  Home                        64%                        62%                       48%
  School                      24%                        14%                       16%
  Farm                        12%                        24%                       36%^∗^
  **Chemical exposure**                                                            
  Agrotoxics                  --                         28%^∗^                    24%^∗^
  Formalin                    --                         10%                       18%
  Others                      --                         38%                       24%
  None                        100%                       24%                       30%
  **Detergent exposure**                                                           
  Yes                         --                         92%                       86%
  No                          --                         8%                        14%
  **Hypochlorite exposure**                                                        
  Yes                         98%                        86%                       80%
  No                          2%                         14%                       20%^∗^
  **Life style**                                                                   
  *Smoke*                                                                          
  Yes                         --                         46%                       48%
  No                          100%                       54%                       52%
  **Alcohol**                                                                      
  Yes                         --                         28%                       24%
  No                          100%                       72%                       76%
  **X-ray exposure**                                                               
  Yes                         32%                        90%^∗^                    100%^∗^
  No                          68%                        10%                       
                                                                                   

a

Values are the mean ± standard deviation.

∗

p

\< 0.05 compared to the control group.

Reproductive age involving events like menarche, menopause and pregnancy, hormone therapy confers risks that can trigger neoplasms ([@B52]) and estrogen alterations ([@B50]).

As observed in the present study, the mean age of the patients was 50 years, with no statistical differences between the groups. An earlier case study on Korean women (*n* = 1026) indicated that the mean age of breast cancer diagnosis was 46.8 years with 14.4 and 26.3 as the age of menarche and first parturition ([@B43]). However, other studies indicated that 2--20% of women diagnosed with breast cancer were under the age of 35 years with tumors that present aggressive biological behavior resulting in mortality and metastasis ([@B42]). Moreover, women's reproductive life, precocious menarche, nulliparity, age of first gestation over 30 years, oral contraceptives, late menopause, and hormone replacement therapy are also well established in relation to breast cancer development ([@B71]; [@B55]; [@B13], [@B14]). Although it is not well documented whether race and cultural differences impart differently on breast cancer induction and progression, yet these factors may have individual roles.

Breast cancer patients are also reported to have exposure to various genotoxic and carcinogenic agents in their domestic activities (detergents and hypochlorites) and occupational contaminants (pesticide) as well as exposure to ionizing radiation before and after diagnosis. Ionizing radiation leads to mutations due to increased chromosomal aberrations and alterations in DNA repair ([@B51]) as well as RT-associated alterations including circulatory problems and secondary cancer ([@B34]). Approximately 50% of RT patients also reported with a smoking habit which is an identified carcinogenic agent with evident increased risk of breast cancer in humans ([@B39]). Similar data (30%) were observed for the consumption of alcoholic beverages, even moderately, may be associated with the risk of breast cancer ([@B71]).

Association between Age and Genetic Instability as an Indicative of Apoptosis and Genotoxicity
----------------------------------------------------------------------------------------------

Before the cancer treatment as well as during RT, nuclear abnormalities (cell death) were statistically increased in patients between 20 and 40 years of age when compared to others. Similar results were found in the range of 41--60 years in relation to the range of 61--80 years age groups indicating that the younger patients are more likely for apoptosis during RT (**Table [2](#T2){ref-type="table"}**). Positive correlations were observed at the basal level between karyorrhexis and age in non-neoplastic cells of the buccal epithelium. Exposure to RT is also not selective with the risks of reaching non-neoplastic tissues ([@B20]; [@B69]). Although the benefits of cancer therapy are inquestionable, the safety aspects cannot be ignored, since these drugs' mechanisms of action can have harmful effects on different tissues ([@B4]).

###### 

Correlation of age with cell death (buccal epithelium) and genotoxicity (lymphocytes).

  Cytogenetic damage      Control         Basal                            Chemotherapy         Radiotherapy
  ----------------------- --------------- -------------------------------- -------------------- ----------------------
  **Buccal epithelium**                                                                         
  *Karyorrhexis*                          *R* = -0.479^∗∗^ (*p* = 0.010)                        
  20--40 years            183.9 ± 77.6    250.0 ± 97.0^ae^                 319.1 ± 90.9^af^     516.1 ± 152.0^abef^
  41--60 years            165.0 ± 103.3   276.6 ± 120.0^acde^              397.5 ± 121.9^acf^   509.7 ± 128.3^abef^
  61--80 years            184.1 ± 104.4   222.0 ± 32.0^ac^                 386.1 ± 189.3^acf^   419.2 ± 153.1^abf^
  *Karyolysis*                                                                                  
  20--40 years            56.5 ± 27.2     87.6 ± 48.2^a^                   93.4 ± 63.3^a^       381.9 ± 147.5^abdef^
  41--60 years            50.6 ± 35.5     94.4 ± 47.9^a^                   81.3 ± 37.7^a^       162.2 ± 67.3^abef^
  61--80 years            73.0 ± 43.2     56.0 ± 21.0^a^                   68.6 ± 22.7^a^       220.0 ± 151.8^abcdf^
  **Lymphocytes**                                                                               
  *Damage index*                                                                                
  20--40 years            19.9 ± 8.2      199.2 ± 41.8^a^                  181.1 ± 60.7^a^      218.1 ± 21.6^abf^
  41--60 years            34.7 ± 16.4     178.2 ± 50.4^a^                  185.7 ± 47.4^a^      204.5 ± 42.9^abf^
  61--80 years            21.1 ± 10.6     193.4 ± 39.7^a^                  179.7 ± 49.5^a^      215.9 ± 38.2^abf^
  *Frequency of damage*                                                                         
  20--40 years            14.4 ± 4.8      79.4 ± 19.1                      90.0 ± 7.0           94.2 ± 7.8^ab^
  41--60 years            16.8 ± 5.9      79.5 ± 18.5                      90.0 ± 10.2          88.4 ± 6.9^ab^
  61--80 years            14.8 ± 6.4      70.0 ± 13.5                      87.2 ± 8.2           96.2 ± 2.5^ab^
                                                                                                

Values represent the mean ± standard deviation. Significance up to

p

\< 0.05.

a

Compared to the control group.

b

Compared to the chemotherapy group.

c

Compared to the age of 20--41 years.

d

Compared to the age of 41--60 years.

e

Compared to the age of 61--80 years.

f

Compared to baseline level.

∗∗

p

values as compared to control group.

During RT and QT, significant increases of karyorrhexes were observed in the buccal epithelium of older patients. Patients with RT showed significant increase in cell death in buccal epithelium as compared to patients undergoing QT. The age in association with hormone receptors status, family history, and genetic aspects may have implications on cancer therapies ([@B54]; [@B55]; [@B45]). Previous studies have shown that young women with triple negative breast tumors have worst prognosis regarding recurrence and mortality ([@B42]; [@B57]). Endocrine factors/reproductive history is mainly related to estrogen stimulation whether endogenous or exogenous, pregnancy after 30 years, nulliparity, use of oral contraceptives (estrogen--progesterone), and postmenopausal hormone replacement therapy (estrogen--progesterone) are all associated with breast cancer incidence ([@B39]; [@B75]).

During cancer development, several pathways may cause genetic instability leading to cell proliferation, inflammation, immune response alterations, and resistance to apoptosis. Genetic instability may induce replicative immortality, cell cycle abnormalities, aneuploidy, and tetraploidy ([@B30]; [@B7]). The genotoxic damage observed in lymphocytes from RT patients was also significant (*p* \< 0.05) as compared to those observed on lymphocytes from patients during QT as well as from baseline and control group (**Table [2](#T2){ref-type="table"}**). No significant statistical differences were observed between the age ranges in relation to genotoxic damages observed. Increased levels of DNA damage and inefficient repair mechanisms are molecular events of many pathogens including cancer ([@B33]). Detection of DNA damage is an initial step toward understanding cellular responses to genotoxic events. Then it is important to know the relationship between drug genotoxicity and checkpoint adaptation during DNA damage mitosis ([@B65]).

Correlations between Occupational Risks and Genetic Instabilities As Indicative of Apoptosis and Genotoxicity
-------------------------------------------------------------------------------------------------------------

Nuclear abnormalities as indicative of cell death in the oral epithelium, especially for karyorrhexis, showed increased levels in patients from QT and RT groups as compared to control. The karyorrhexes observed for domestic occupation were significant in relation to the risks of school and agricultural activities especially for patients in RT. Cell death observed in RT group was also significant in relation to QT group (**Table [3](#T3){ref-type="table"}**). Previous studies have reported that occupational exposure to pesticides has effects on the frequency of micronuclei in oral mucosal cells with cytogenetic damage in somatic cells and correlations between some genotoxicity biomarkers ([@B11]; [@B18]). According to [@B58], occupational exposure to chemicals in women involved in agriculture and/or industry should be monitored in epidemiological studies.

###### 

Correlation of occupational risks with cell death (buccal epithelium) and genotoxicity (lymphocytes).

  Cytogenetic damage      Control           Basal               Chemotherapy       Radiotherapy
  ----------------------- ----------------- ------------------- ------------------ -------------------
  **Buccal epithelium**                                                            
  *Karyorrhexis*                                                                   
  Home                    184.8 ± 66.3^d^   248.1 ± 69.8^acd^   368.4 ± 64.2^a^    391.5 ± 68.5^ab^
  School                  187.7 ± 53.4^d^   224.8 ± 37.8^a^     378.5 ± 72.2^a^    468.6 ± 65.9^ab^
  Agricultural activity   147.2 ± 75.2      340.3 ± 74.4^a^     379.9 ± 77.8^a^    428.4 ± 75.7^abe^
  *Karyolysis*                                                                     
  Home                    55.3 ± 39.8       94.7 ± 68.3^a^      98.1 ± 58.2^ac^    175.1 ± 69.3^abe^
  School                  50.0 ± 36.5       113.4 ± 34.2^ae^    56.1 ± 43.4^a^     174.5 ± 55.9^ab^
  Agricultural activity   67.0 ± 37.9       85.5 ± 66.6^a^      90.4 ± 50.8^ac^    177.5 ± 89.9^abe^
  **Lymphocytes**                                                                  
  *Damage index*                                                                   
  Home                    26.2 ± 14.1       139.7 ± 58.8^ac^    193.9 ± 48.1^ac^   189.8 ± 62.9^a^
  School                  17.2 ± 8.7^d^     181.2 ± 73.0^ad^    231.7 ± 68.0^ad^   220.6 ± 64.2^a^
  Agricultural activity   41.0 ± 21.9       138.5 ± 60.3^a^     178.4 ± 48.3^a^    215.2 ± 72.2^ab^
  *Frequency of damage*                                                            
  Home                    15.8 ± 10.2       72.4 ± 17.3^ac^     90.5 ± 11.0^a^     86.5 ± 12.7^a^
  School                  12.6 ± 5.2        91.4 ± 14.2^a^      91.5 ± 12.4^a^     93.2 ± 7.7^a^
  Agricultural activity   19.6 ± 8.8        80.5 ± 17.0^a^      89.2 ± 10.4^a^     89.3 ± 17.2^a^
                                                                                   

Values represent the mean ± standard deviation. Significance up to

p

\< 0.05.

a

Compared to the control group.

b

Compared to the chemotherapy group.

c

Compared to individuals who answered "school."

d

Compared to individuals who answered "agriculture."

e

Compared to baseline damage.

Basal genotoxic damages of lymphocytes in patients before QT and RT were statistically significant as compared to control. Likewise, patients with RT showed more genotoxic lymphocyte damage that QT patients. QT patients exposed to agricultural activities showed significant increase in genotoxic damage as compared to patients with home and school activities. However, this significance was not observed in the genotoxic damage to the lymphocytes of patients in radiotherapies (**Table [3](#T3){ref-type="table"}**). Lymphocytes isolated from peripheral blood and exfoliated cells of the buccal epithelium are used to determine the effects of mutagens based on cytogenetic markers such as chromosomal aberrations, micronuclei, chromatid breaks, and comet assay ([@B28]; [@B36]).

Association between Smoking and Genetic Instability As Indicative of Cell Death and Genotoxicity
------------------------------------------------------------------------------------------------

Nuclear abnormalities in patients with smoking habit prior to breast cancer diagnosis were significantly increased during QT and RT at baseline and during treatment (**Table [4](#T4){ref-type="table"}**). Smoking can induce significant changes in DNA, as indicated by cytogenetic biomarkers, and increases the risk of cancer by elevating levels of micronuclei in buccal mucosa epithelial cells ([@B19]; [@B18]). However, smoking did not significantly influence the DI and DF in lymphocytes in QT patients with reported smoking. However, RT patients showed increase in the genotoxicity parameters as compared to QT patients in relation to non-smokers before the diagnosis for breast cancer.

###### 

Correlation of smoking with cell death (buccal epithelium) and genotoxicity (lymphocytes).

  Cytogenetic damage      Basal             Chemotherapy      Radiotherapy
  ----------------------- ----------------- ----------------- ------------------------------
  **Buccal epithelium**                                       
  *Karyorrhexis*                                              
  Yes                     289.0 ± 79.6^b^   367.2 ± 63.0^b^   485.6 ± 81.0^abc^
  No                      239.1 ± 67.8      285.2 ± 72.1      451.3 ± 76.3^ac^
  *Karyolysis*                                                *r* = 0.411^∗^ (*p* = 0.003)
  Yes                     86.2 ± 51.0       94.7 ± 61.3       293.3 ± 82.0^abc^
  No                      86.9 ± 54.8       105.3 ± 56.2      124.1 ± 69.6^a^
  **Lymphocytes**                                             
  *Damage index*                                              
  Yes                     152.8 ± 67.1      197.7 ± 58.6      208.4 ± 56.1^c^
  No                      145.7 ± 50.3      181.3 ± 57.4      214.9 ± 66.9^a^
  *Frequency of damage*                                       
  Yes                     78.1 ± 20.1       88.7 ± 11.4       92.4 ± 8.5
  No                      81.2 ± 17.3       91.7 ± 8.8        88.8 ± 15.9
                                                              

Values represent the mean ± standard deviation. Significance up to

p

\< 0.05.

a

Compared to the chemotherapy group.

b

Compared to individuals who answered "no."

c

Compared to baseline damage.

∗

p

values as compared to control group.

Smoking, a factor studied over the years with contradictory results, is currently recognized by the IARC as a carcinogenic agent with evidence of increased risk of breast cancer in humans ([@B39]). Genotoxic evaluation using comet assay showed significant differences among smokers, non-smokers, and passive smokers, demonstrating induction of oxidative damages ([@B76]). Positive correlations were observed between smoking and karyolysis in patients during RT (**Figure [1](#F1){ref-type="fig"}**). Moreover, studies also indicated the genotoxic effects of tobacco on oral epithelium ([@B72]; [@B73]) and mutagenic effects by micronuclei, karyorrhexis, karyolysis, and binucleate cells ([@B27]). However, numerous reports indicate that there are no associations between smokers and increased DNA migration in peripheral lymphocytes of smokers of more than 20 cigarettes per day ([@B64], [@B63]).

![Correlation between smoking and karyolysis in buccal epithelium of breast cancer patients during radiotherapy. Spearman's correlation ^∗^*p* \< 0.05.](fgene-08-00236-g001){#F1}

Correlations between Smoking and Genetic Instability As Indicative of Cell Death and Genotoxicity in Breast Cancer Patients
---------------------------------------------------------------------------------------------------------------------------

Patients on QT and RT with alcohol consumption showed increased apoptosis levels in the buccal epithelium. Radiation therapy also increased the levels of biomarkers. Patients who reported consumption of alcoholic beverages at the baseline level did not show increase in DI and DF. However, during QT, these damages were significantly increased in patients who did not consume alcohol. No correlation was observed between ethylism and the cytogenetic biomarkers evaluated (**Table [5](#T5){ref-type="table"}**). There is still limited evidence of smoking with the risk for breast cancer ([@B32]; [@B59]).

###### 

Correlation of alcohol consumption with cell death (buccal epithelium) and genotoxicity (lymphocytes).

  Cytogenetic damage      Basal             Chemotherapy      Radiotherapy
  ----------------------- ----------------- ----------------- -------------------
  **Buccal epithelium**                                       
  *Karyorrhexis*                                              
  Yes                     271.8 ± 93.5^b^   333.7 ± 83.1^b^   562.9 ± 79.3^abc^
  No                      212.1 ± 76.9      393.7 ± 82.7      439.5 ± 97.1^a^
  *Karyolysis*                                                
  Yes                     109.7 ± 65.7^b^   123.1 ± 80.2^b^   219.2 ± 53.1^abc^
  No                      79.0 ± 46.7       91.6 ± 63.1       189.6 ± 87.8^a^
  **Lymphocytes**                                             
  *Damage index*                                              
  Yes                     147.5 ± 63.5      192.1 ± 59.8^b^   201.3 ± 45.1
  No                      149.5 ± 56.8      169.2 ± 32.1      215.1 ± 65.9^a^
  *Frequency of damage*                                       
  Yes                     79.8 ± 19.2       89.3 ± 10.8       93.9 ± 4.7
  No                      77.7 ± 18.5       90.7 ± 9.9        89.5 ± 14.4
                                                              

Values represent the mean ± standard deviation. Significance up to

p

\< 0.05.

a

Compared to the chemotherapy group.

b

Compared to individuals who answered "no."

c

Compared to baseline damage.

Alcohol consumption is positively associated with breast cancer in menopausal women with more than 10 g/day ([@B44]). In postmenopausal women, there are associations between lifestyle (consumption of alcohol and tobacco) and inadequate diet with breast cancer. Thus, breast cancer preventive measures include no alcohol consumption (or only moderate), healthy diet, and physical activity ([@B48]). Interactions between lifestyle and dietary factors with genes are pointed out, for instance, the association with the MAPK genes such as MAPK 14 (p38) which may interact with alcohol, diet and lifestyle ([@B62]). Although the biological mechanism has not yet been well elucidated, there is proven evidence that alcohol induces chromosomal instability resulting in aneuploidy events which are associated with cancer. In addition, the induction of oxidative damage, DNA adducts, crosslinks and DNA strand breaks can result in reactive oxygen species, lipid peroxidation product and acetaldehyde ([@B12]; [@B29]). Interestingly the moderate consumption of alcohol reduced the risk of breast cancer by about 30% ([@B22]; [@B37]).

Correlations between Ionizing Radiation and Genetic Instability As Indicative of Cell Death and Genotoxicity
------------------------------------------------------------------------------------------------------------

Patients were also reported to exposure of ionizing radiations (**Table [1](#T1){ref-type="table"}**). At baseline, nuclear abnormalities of the buccal epithelium of patients who underwent RT and QT were significantly increased as compared to the control. RT also induced more cell death (karyorrhexis and karyolysis) when compared to QT. Positive correlations were observed between exposure to ionizing radiation and cell death by karyolysis in patients during QT as well as for DF at baseline and during QT as well (**Table [6](#T6){ref-type="table"}**).

###### 

Correlation of ionizing radiation with cell death (buccal epithelium) and genotoxicity (lymphocytes).

  Cytogenetic damage      Control           Basal                          Chemotherapy                    Radiotherapy
  ----------------------- ----------------- ------------------------------ ------------------------------- --------------------
  **Buccal epithelium**                                                                                    
  *Karyorrhexis*                                                                                           
  Yes                     172.3 ± 79.4^c^   250.9 ± 87.3^a^                355.2 ± 81.4^ad^                469.1 ± 169.7^abd^
  No                      154.8 ± 84.2      --                             346.6 ± 73.9^a^                 --
  *Karyolysis*                                                             *R* = 0.298^∗^ (*p* = 0.042)    
  Yes                     58.7 ± 45.0       86.7 ± 52.5^a^                 107.5 ± 86.4^acd^               210.9 ± 83.2^abd^
  No                      45.3 ± 22.3       --                             50.2 ± 15.5                     --
  **Lymphocytes**                                                                                          
  *Damage index*                                                                                           
  Yes                     23.5 ± 18.1       157.0 ± 56.9^ac^               191.2 ± 56.9^ac^                211.8 ± 61.4^a^
  No                      29.1 ± 23.9       87.8 ± 25.3^a^                 151.0 ± 29.7^a^                 --
  *Frequency of damage*                     *R* = 0.279^∗^ (*p* = 0.050)   *R* = 0.391^∗∗^ (*p* = 0.005)   
  Yes                     14.7 ± 7.9        81.7 ± 18.7^ac^                91.6 ± 9.8^a^                   90.6 ± 12.9^a^
  No                      16.3 ± 9.7        62.4 ± 5.7^a^                  82.0 ± 7.7^a^                   --
                                                                                                           

Values represent the mean ± standard deviation. Significance up to

p

\< 0.05.

a

Compared to the control group.

b

Compared to the chemotherapy group.

c

Compared to individuals who answered "no."

d

Compared to baseline damage levels.

∗

,

∗∗

p

values as compared to control group.

Ionizing radiations are known to increase cancer risk ([@B56]; [@B41]) especially in patients undergoing further medical examinations ([@B41]). RT significantly increases DNA damage in lymphocyte in relation to QT and causes damage to repair genes ([@B66]). Exposure to X-rays induces significant increase in genotoxicity parameters (DI and DF) in peripheral blood lymphocytes of breast cancer patients compared to baseline levels in controls (**Table [6](#T6){ref-type="table"}**). Ionizing radiation induces DNA damage and is known to be carcinogenic as it can cause DNA strand breaks as well as chromosomal rearrangements ([@B10]). Double strand breaks are the most deleterious lesions induced by ionizing radiations which can lead to cell death due to their acute toxicities ([@B9]). In addition to strand breaks, ionizing radiations induce damage to the chromosomal DNA, abasic sites, base and sugar oxidations, and cross-links ([@B24]).

Exposure of DNA to radiation induces a signal transduction cascade resulting in damage to the genetic material, DNA strand breaks, including increased reactive oxygen species ([@B46]; [@B49]; [@B69]), and induction of chromosomal aberrations and apoptosis ([@B67]). Tumor suppressor genes such as p53 and PTEN can be deregulated resulting in impairment of important functions such as induction of apoptosis, activation of the repair system and cell cycle arrest ([@B35]). RT increases the survival rate in cancer patients ([@B31]) but may lead to clinical complications ([@B69].) like genetic instability ([@B25]). The effects and low doses of radiation are still uncertain but in women with germline mutations in *BRCA1* and *BRCA2* genes, an association with radiological diagnoses exists especially after 50 years of age ([@B40]).

Conclusion
==========

At the baseline, breast cancer patients already showed increased DNA damage in the oral epithelium (karyorrhexis and karyolysis) and lymphocytes (DI and DF) in relation to the control group. Our result indicating genetic instability were significantly increased during cancer therapies (QT and RT). The cytogenetic damages assessed during RT were bigger than those evidenced during QT. Cytogenetic damages were differentiated for risk factors (age, workplace, smoking, alcoholism, and exposure to X-rays) for genetic instability. Considering the age as risk factor for nuclear abnormalities indicative of cell death (karyorrhexis and karyolysis) were more evident in younger women and during the menopausal period as compared to women aged over 60 years. Negative correlations were found between age and nuclear abnormalities at the baseline level. These relationships were not observed for genotoxic damage in lymphocytes. Patients who reported smoking habit presented more karyorrhexis and karyolysis in the buccal epithelium; and genotoxicity in lymphocytes before (baseline) and during QT and RT. However, positive correlations were evidenced only between smoking and karyolysis for patients undergoing RT.
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